G
002275
vs
S
Shanghai Composite
Over the past 12 months, Guilin Sanjin Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of +0% compared to the Shanghai Composite's +23% growth.
Stocks Performance
002275 vs Shanghai Composite
Performance Gap
002275 vs Shanghai Composite
Performance By Year
002275 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Guilin Sanjin Pharmaceutical Co Ltd
Glance View
Guilin Sanjin Pharmaceutical Co. Ltd., deeply rooted in the lush landscapes of Guangxi, China, has woven itself into the tapestry of the healthcare industry through its expertise in traditional Chinese medicine (TCM). Established in 1994, the company possesses a rich legacy of harnessing nature's bounty to create medically beneficial products. Anchored in the cultural heritage and time-tested practices of TCM, Guilin Sanjin transforms rare and native ingredients into innovative over-the-counter pharmaceuticals and health supplements. Notably, the company is renowned for its Sanjin Watermelon Frost, a herbal remedy that has become a household name in China for its soothing properties on throat ailments. At the heart of Guilin Sanjin's business model lies a robust integration of research, development, and manufacturing. By maintaining diversified revenue streams, the company capitalizes on the synergy between time-honored traditions and modern scientific advancements. They continually enhance their product offerings through their dedicated research centers, focused on expanding their portfolio beyond the treatment of minor ailments to include lifestyle and wellness products. By embracing stringent quality controls and adhering to international standards, Guilin Sanjin has carved a path not just domestically but also in global markets, fortifying its position as a stalwart of TCM. Through a well-coordinated distribution network, the company ensures that its products are readily accessible, driving sustained growth and ensuring its relevance in a rapidly evolving healthcare landscape.
